Welcome to our dedicated page for AvePoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AvePoint, Inc. filings document the company’s financial results, governance matters, capital structure and public-company securities activity. Form 8-K reports furnish quarterly and annual operating results, including SaaS revenue, total revenue, annual recurring revenue and related financial-condition disclosures tied to the company’s cloud data protection business.
Proxy materials and annual meeting reports cover director elections, executive compensation votes, auditor ratification and board governance. Other filings address common stock offering activity under shelf registration materials, the company’s secondary listing context for common stock, and the removal of AvePoint warrants from Nasdaq listing and registration.
AvePoint reported strong growth and improving profitability for Q4 and full year 2025. Fourth-quarter revenue reached $114.7 million, up 29%, with SaaS revenue of $88.9 million, up 37%. Q4 GAAP operating income rose to $14.5 million, lifting GAAP operating margin to 12.7%.
For 2025, total revenue was $419.5 million, up 27%, including SaaS revenue of $319.2 million, up 38%. Full-year GAAP operating income increased to $33.0 million from $7.2 million, while non-GAAP operating income grew to $79.2 million, with a non-GAAP operating margin of 18.9%. Annual recurring revenue reached $416.8 million, up 27%.
The company ended 2025 with cash and cash equivalents of $481.1 million and generated $85.3 million of cash from operations. For 2026, AvePoint guides to total revenue of $509.4–$517.4 million, ARR of $525.1–$531.1 million, and non-GAAP operating income of $92.6–$96.6 million, implying continued double-digit growth and margin expansion.
AvePoint, Inc. director and Chief Legal Officer Brian Michael Brown reported an exempt insider transaction related to equity compensation. On 02/04/2026, 322 shares of common stock were withheld by the company at $10.53 per share to cover tax obligations tied to vesting securities under the 2021 Equity Incentive Plan, rather than sold at his discretion. After this withholding, he beneficially owns 644,107 shares, including both common stock and vested and unvested restricted stock units that each convert into one share upon vesting.
AvePoint, Inc. insider entities reported planned stock sales. Trusts and LLCs associated with Executive Chairman and director Gong Xunkai sold 32,002 shares of common stock on January 12, 2026 at $13.66 per share and 27,998 shares on January 13, 2026 at $13.39 per share. Both transactions were indirect, reported as "Held by trusts and LLCs."
After these sales, entities associated with Mr. Gong beneficially owned 14,948,666 shares and 14,920,668 shares, respectively, on an indirect basis. The sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on June 22, 2025, and the report notes that he may be deemed to beneficially own certain affiliate- and trust-held shares while disclaiming beneficial ownership except to the extent of his pecuniary interest.
Form 144 discloses a planned sale of 60,000 shares of common stock of the issuer through The Charles Schwab Corporation, with an approximate sale date of 01/12/2026 on the NASDAQ. The shares to be sold are described as founders shares, acquired from the issuer on 01/02/2006, with 215,789,313 common shares stated as outstanding. The notice also lists recent sales by Xunkai Gong, including multiple common stock transactions in November and December 2025 with disclosed gross proceeds for each sale.
AvePoint director and Chief Legal Officer Brian Michael Brown reported insider equity transactions involving company stock and awards. On December 12, 2025, he acquired 21,000 shares of AvePoint common stock in connection with the exercise of stock options at a reported price of $13.89 per share. In a related exempt transaction under Rule 16b-3, 5,010 shares were withheld by AvePoint to satisfy the exercise price or tax obligations, rather than sold at his discretion. After these transactions, he beneficially owned 645,048 shares of common stock and restricted stock units in total, and held 2,265,102 stock options, all reported as directly owned.
AvePoint, Inc.’s chief financial officer reported a routine tax-related share withholding connected to equity compensation. On 12/12/2025, 6,120 shares of common stock were withheld at $13.89 per share to cover income tax obligations arising from the vesting or settlement of restricted stock units (RSUs) granted under the company’s 2021 Equity Incentive Plan.
This exempt transaction did not reflect a discretionary sale by the officer. After the withholding, the officer beneficially owns 200,130 shares of AvePoint common stock, including both regular shares and vested and unvested RSUs, each RSU representing the right to receive one share upon vesting.
AvePoint, Inc.'s Chief Executive Officer, who is also a director, reported an automatic tax-withholding transaction involving company stock. On 12/12/2025, 2,914 shares of AvePoint common stock were withheld by the company at a price of $13.89 per share to satisfy income tax obligations triggered by the vesting or settlement of restricted stock units (RSUs) granted under the 2021 Equity Incentive Plan. The filing characterizes this as an exempt Rule 16b-3 transaction and notes that it does not represent a discretionary trade by the insider. After this withholding, the reporting person beneficially owned 2,150,588 shares of AvePoint common stock, including both non-RSU shares and vested and unvested RSUs.
AvePoint, Inc. disclosed that its executive chairman and director had 4,025 shares of common stock withheld on December 12, 2025 to satisfy tax and related obligations arising from the vesting or settlement of equity awards, at a price of $13.89 per share. The company explains this was an exempt, non-discretionary transaction in which shares were delivered or withheld to cover income tax withholding and remittance obligations.
The reported holdings after this event total 759,677 shares beneficially owned directly, which include both non‑RSU common stock and aggregate vested and unvested restricted stock units granted under AvePoint’s 2021 Equity Incentive Plan. Each RSU represents the right to receive one share of common stock upon vesting.
AvePoint, Inc. reported Q3 2025 results. Total revenue was $109.7 million, driven by SaaS $83.98 million, services $13.77 million, term license and support $11.14 million, and maintenance $0.84 million. Gross profit reached $81.58 million, with income from operations of $8.13 million and other income of $4.68 million, resulting in net income of $13.02 million and diluted EPS of $0.06.
Cash and cash equivalents were $471.64 million as of September 30, 2025, supported by warrant exercises that generated $168.19 million year to date. Deferred revenue totaled $174.20 million, and remaining performance obligations were $475.2 million, with approximately 57% expected to be recognized over the next twelve months.
During the quarter, AvePoint completed an acquisition of Ydentic with estimated consideration of $20.4 million. The company also executed its share repurchase program, retiring 1,743,455 shares year to date for $27.31 million. AvePoint completed a secondary listing on the SGX in connection with a secondary offering; AvePoint did not receive proceeds from those share sales.
AvePoint, Inc. (AVPT) furnished an 8-K announcing it issued a press release reporting financial results for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and the information under Item 2.02 is being furnished, not filed, under the Exchange Act.